Home・Aandelen Lijst・Boston Scientific Corp.

Boston Scientific Corp.

Gesloten

SectorGezondheidszorg

42.96 -0.28

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

42.78

Max

43.53

Belangrijke statistieken
By Trading Economics
Inkomsten	-437M 904M
Verkoop	239M 5.4B
K/W Sectorgemiddelde	19.352 56.597
EPS	0.86
Winstmarge	16.612
Werknemers	59,000
EBITDA	-214M 1.4B

Dividenden
By Acuity
Volgende Winsten	28 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	1.6B 69B
Vorige openingsprijs	43.24
Vorige sluitingsprijs	42.96

Nieuwssentiment

By Acuity

88%

12%

319 / 339 Rangschikking in Healthcare

Boston Scientific Corp. Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 sep 2026, 23:01 UTC

Boston Scientific shares are trading higher in after-market hours. The U.S. budget deficit for August was $167 billion, narrower than expected.

10 sep 2026, 23:31 UTC

Boston Scientific Corp shares are higher in after-market hours, though no specific news was identified for the price movement. The broader market also showed notable gains.

9 sep 2026, 20:07 UTC

News

Social Media

Boston Scientific shares are advancing today following Citi's report on network restoration and BTIG's maintained Buy rating, despite a lowered price target of $56.

8 sep 2026, 23:01 UTC

Social Media

Boston Scientific Corp shares rose in after-market trading, reflecting positive movement since Tuesday's close amid notable options activity discussed on social media.

4 sep 2026, 23:05 UTC

Boston Scientific Corp shares are lower in after-market trading amid mixed economic signals, including a slight rise in unemployment and increased Treasury yields.

3 sep 2026, 20:02 UTC

News

Macro Event

Boston Scientific Corp is under scrutiny after notifying customers about the removal of Infinion CX leads linked to serious injuries, contributing to a stock decline.

2 sep 2026, 23:21 UTC

Boston Scientific shares are higher in after-market trading, despite no specific news. Weaker job growth data may influence Federal Reserve interest rate expectations.

1 sep 2026, 23:06 UTC

Boston Scientific Corp shares are lower in after-market hours, fluctuating within a narrow range and remaining below the 20-day moving average. No specific news was identified.

31 aug 2026, 23:06 UTC

Boston Scientific shares are higher in after-market trading, with no specific news identified. Broader market sentiment reflects heightened expectations for a Federal Reserve rate hike.

28 aug 2026, 23:06 UTC

Boston Scientific Corp. shares traded roughly flat in after-market hours, with no specific news identified and a slight cumulative return of 0.01%.

27 aug 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market hours. No specific company news was identified to explain the movement, amid broader labor market data.

26 aug 2026, 23:01 UTC

News

Boston Scientific shares rise in after-market hours, supported by positive market sentiment despite recent operational challenges from a cybersecurity incident affecting IT systems.

25 aug 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market trading, amid a broader market reaction to a significant drop in crude oil prices.

24 aug 2026, 20:01 UTC

News

Boston Scientific Corp shares are lower amid broader market declines linked to geopolitical tensions and concerns over oil supply disruptions affecting investor sentiment.

22 aug 2026, 00:01 UTC

Boston Scientific Corp is trading higher in after-market hours, reflecting broader market gains despite no specific company news driving the movement.

21 aug 2026, 23:01 UTC

Boston Scientific shares are higher in after-market trading, positioned above their 20-day moving average and near the upper end of their one-month range.

20 aug 2026, 22:51 UTC

Boston Scientific shares are higher in after-market trading, reflecting a gain since Thursday's close and remaining above the 20-day moving average.

19 aug 2026, 20:02 UTC

Boston Scientific shares are higher as the Health Care Equipment sector shows strong momentum. The stock is trading with unusually high volume today.

18 aug 2026, 23:06 UTC

Boston Scientific Corp shares are trading higher in after-market hours, remaining above their 20-day moving average amid broader market pressures from rising bond yields.

17 aug 2026, 23:16 UTC

Boston Scientific shares are higher in after-market hours, showing a slight gain since Monday's close. The stock remains stable near its one-month range.

15 aug 2026, 00:01 UTC

Boston Scientific Corp shares are higher in after-market hours, continuing a trend of six consecutive sessions of gains. No specific news was identified for this movement.

14 aug 2026, 23:01 UTC

Boston Scientific Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions finishing higher. No specific news was identified.

13 aug 2026, 23:01 UTC

Social Media

Boston Scientific shares are higher in after-market trading, buoyed by social media discussions of the CEO's $9 million stock purchase amid a significant year-to-date decline.

12 aug 2026, 23:06 UTC

Boston Scientific Corp shares are modestly higher in after-market trading. The stock remains significantly above its 20-day moving average.

11 aug 2026, 23:41 UTC

Boston Scientific Corp shares are lower in after-market trading, showing unusual volatility and reflecting a broader trend of weakness since Tuesday's close.

10 aug 2026, 23:06 UTC

Boston Scientific shares are trading higher in after-market hours, amid mixed market sentiment influenced by geopolitical tensions, particularly concerning the Strait of Hormuz.

8 aug 2026, 00:01 UTC

Boston Scientific Corp shares are higher in after-market trading, reflecting gains since Friday's close and remaining above their 20-day moving average.

7 aug 2026, 23:21 UTC

Boston Scientific shares are higher in after-market hours following a Labor Department report showing a decline in non-farm payroll employment, reducing interest rate hike expectations.

6 aug 2026, 23:01 UTC

Boston Scientific Corp shares are higher during after-market hours, reflecting a generally strong performance backdrop amid resilient labor market data.

5 aug 2026, 23:02 UTC

Social Media

News

Boston Scientific Corp shares rose in after-market trading following CEO Mahoney's purchase of 186,240 shares at an average price of $48.33.

Peer Vergelijking

Prijswijziging

Boston Scientific Corp. Prognose

Beoordelingsconsensus

By TipRanks

Strong Buy

21 ratings

Buy

Hold

Sell

Gebaseerd op 21 analisten die aandelenratings hebben gegeven aan Boston Scientific Corp. - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

319 / 339 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.